KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Outstanding (Weighted Average) (2016 - 2025)

Jazz Pharmaceuticals has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $61.0 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 1.39% to $61.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.0 million through Dec 2025, down 1.39% year-over-year, with the annual reading at $61.0 million for FY2025, 1.39% down from the prior year.
  • Shares Outstanding (Weighted Average) was $61.0 million for Q4 2025 at Jazz Pharmaceuticals, roughly flat from $60.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $63.7 million in Q2 2023 and troughed at $56.5 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $61.9 million (2022), against an average of $61.5 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 9.56% in 2022 and later decreased 2.69% in 2024.
  • Tracing JAZZ's Shares Outstanding (Weighted Average) over 5 years: stood at $59.7 million in 2021, then rose by 4.77% to $62.5 million in 2022, then grew by 1.2% to $63.3 million in 2023, then fell by 2.3% to $61.8 million in 2024, then decreased by 1.39% to $61.0 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $61.0 million, $60.7 million, and $61.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.